S. Howell

发表

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

David F. Smith, Catrin Tudur Smith, A. Marson, 2007, The Lancet.

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

Jing Shen, Paula R Williamson, Anthony G Marson, 2007, The Lancet.

Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene.

G. Davies-Jones, G. Plant, J. Collinge, 1999, Brain : a journal of neurology.

A randomised controlled trial of treatment for idiopathic intracranial hypertension

B. Sharrack, S. Howell, C. Clarke, 2011, Journal of Neurology.

The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre

M. Reuber, S. Howell, A. Brockington, 2020, Seizure.

Bilirubin, ferritin, D-dimers and erythrophages in the cerebrospinal fluid of patients with suspected subarachnoid haemorrhage but negative computed tomography scans.

S. Howell, C. Smith, K. B. Page, 1994, Journal of clinical pathology.

M. Reuber, S. Howell, D. Aeschlimann, 2018, Seizure.

Differential diagnosis of seizure disorders: a conversation analytic approach.

M. Reuber, S. Howell, Meike Schwabe, 2007, Social science & medicine.

Machine learning as a diagnostic decision aid for patients with transient loss of consciousness.

S. Sisodiya, M. Koepp, M. Reuber, 2019, Neurology. Clinical practice.

Autoantibodies to glutamic acid decarboxylase in patients with epilepsy and their relationship with type 1 diabetes: a pilot study

S. Howell, A. Vincent, I. Idris, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Psychogenic nonepileptic seizure manifestations reported by patients and witnesses

S. Sisodiya, M. Koepp, M. Reuber, 2011, Epilepsia.

Value of patient-reported symptoms in the diagnosis of transient loss of consciousness

D. Hesdorffer, S. Sisodiya, M. Koepp, 2016, Neurology.

Adversarial Growth in Patients with Multiple Sclerosis and their Partners: Relationships with Illness Perceptions, Disability and Distress

B. Sharrack, S. Howell, C. Isaac, 2011, Journal of Clinical Psychology in Medical Settings.

A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy.

Michael R. Johnson, David F. Smith, C. Hoggart, 2014, Human molecular genetics.

Accelerated long-term forgetting in temporal lobe but not idiopathic generalised epilepsy

N. Hunkin, N. Muhlert, M. Reuber, 2011, Neuropsychologia.

Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy

M. Brodie, S. Howell, A. Vincent, 2013, Epilepsia.

Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial

Mark Johnson, J. Read, J. Mellers, 2020, The lancet. Psychiatry.

Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.

A. Marson, G. Baker, C. Tudur-Smith, 2021, Health technology assessment.

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

U. Wieshmann, A. Chaudhuri, J. Gibb, 2021, The Lancet.

Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24.

C. Marsden, I. Scheffer, Í. Lopes-Cendes, 1998, American journal of human genetics.

PHENYTOIN AND CEREBELLAR ATAXIA: NOT ALL DOWN TO TOXICITY?

M. Reuber, S. Howell, N. Hoggard, 2013, Journal of Neurology, Neurosurgery & Psychiatry.

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

U. Wieshmann, A. Chaudhuri, J. Gibb, 2021, The Lancet.

Value of witness observations in the differential diagnosis of transient loss of consciousness

D. Hesdorffer, S. Sisodiya, M. Koepp, 2019, Neurology.

A district epilepsy service, with community-based specialist liaison nurses and guidelines for shared care

S. Howell, M. Taylor, S. Readman, 1994, Seizure.

Severe autosomal dominant nocturnal frontal lobe epilepsy associated with psychiatric disorders and intellectual disability

I. Scheffer, J. Duncan, S. Berkovic, 2008, Epilepsia.

Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies

Arjune Sen, S. Howell, J. Adcock, 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

Edinburgh Research Explorer Characteristics of 698 patients with dissociative seizures: A UK multicenter study

J. Mellers, L. Goldstein, M. Richardson, 2022 .

Idiopathic generalised epilepsy: a pilot study of memory and neuronal dysfunction in the temporal lobes, assessed by magnetic resonance spectroscopy

I. Wilkinson, P. Griffiths, S. Howell, 2006, Journal of Neurology, Neurosurgery & Psychiatry.